Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2, Multi-Center, Open-Label Clinical Study Evaluating MDX2004 In Participants With Advanced Tumors

NCT07110584 is registered in ClinicalTrials.gov with ModeX Therapeutics, An OPKO Health Company as lead sponsor.

NCT NCT07110584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07110584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2, Multi-Center, Open-Label Clinical Study Evaluating MDX2004 In Participants With Advanced Tumors
Lead sponsor
ModeX Therapeutics, An OPKO Health Company
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 1, 2025
Completion date
June 30, 2031
Enrollment
235 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced tumors